substance p has been researched along with Diarrhea in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Hou, YJ; Jiang, HL; Li, Y; Wang, K; Yao, JP; Zhou, SY | 1 |
| Choi, HS; Jang, KS; Jun, DW; Lee, HL; Lee, KN; Lee, OY; Lee, SP; Sim, J; Sohn, W; Yoon, BC | 1 |
| Barrett, KE; Camilleri, M; Sellin, JH | 1 |
| Agerberth, B; Alam, NH; Andersson, J; Bhuiyan, TR; Bishop, AE; Mathan, M; Qadri, F; Raqib, R; Sarker, P; Wretlind, B | 1 |
| Banks, MR; Kent, AJ | 1 |
| Hu, R; Tang, F | 1 |
| Abrahamsson, H; Björnsson, ES; Simrén, M; Sjövall, H; Stotzer, PO | 1 |
| Actor, JK; Chappell, CL; Lewis, DE; Okhuysen, PC; Robinson, P; Weinstock, JV; White, AC | 1 |
| Anton, PM; Brown, D; Gay, J; Karalis, K; Mykoniatis, A; O'Brien, M; Pan, A; Pothoulakis, C | 1 |
| Fang, XC; Pan, GZ; Wang, LH | 1 |
| Crentsil, V | 1 |
| Farthing, MJ | 2 |
| Koster, AS; Kraneveld, AD; Nijkamp, FP; Rijnierse, A; van Zijl, KM | 1 |
| Achem-Karam, S; Owyang, C; Vinik, AI | 1 |
| Castagliuolo, I; Jaffer, A; LaMont, JT; Leeman, SE; O'Keane, JC; Pothoulakis, C; Snider, RM | 1 |
| Goldin, E; Karmeli, F; Lysy, J; Sestieri, M; Yatzkan, Y | 1 |
| Camilleri, M; Homburger, HA; Klee, GG; O'Brien, MD; Pitot, HC; Rubin, J; Saslow, SB; von der Ohe, M | 1 |
| Bobrowski, P; Charbonnet, RM; Lao, J; MacNaughton, WK; Miller, MJ; Sandoval, M; Thompson, JH; Trentacosti, AM; Zhang, XJ | 1 |
| Chang, FY; Chang, SS; Chen, CY; Kang, LJ; Lee, SD; Lu, CL; Lu, RH | 1 |
| Zhang, ZB | 1 |
| Degryse, A; Ooms, L | 1 |
6 review(s) available for substance p and Diarrhea
| Article | Year |
|---|---|
Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.
Topics: C-Reactive Protein; Chromogranins; Chronic Disease; Diarrhea; Feces; Gastrointestinal Motility; Humans; Inflammation; Intestinal Absorption; Intestinal Mucosa; Intestinal Secretions; Intestines; Irritable Bowel Syndrome; Lactoferrin; Leukocyte L1 Antigen Complex; Osmolar Concentration; Permeability; Prostaglandins; Serotonin; Substance P | 2017 |
Pharmacological management of diarrhea.
Topics: Anti-Infective Agents; Antidiarrheals; Bismuth; Calcium Channel Blockers; Calmodulin; Chloride Channels; Cholestyramine Resin; Diarrhea; Fluid Therapy; Humans; Narcotics; Neprilysin; Receptors, sigma; Serotonin Antagonists; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2010 |
Antisecretory drugs for diarrheal disease.
Topics: Antidiarrheals; Chloride Channels; Diarrhea; Enzyme Inhibitors; Humans; Intestinal Mucosa; Neprilysin; Receptors, Vasoactive Intestinal Peptide; Serotonin Antagonists; Substance P; Treatment Outcome | 2006 |
Gastrointestinal hormones in clinical medicine.
Topics: Chemical Phenomena; Chemistry; Cholecystokinin; Diabetes Mellitus; Diarrhea; Endocrine System Diseases; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon; Humans; Hypoglycemia; Motilin; Neoplasms; Neurotensin; Pancreatic Polypeptide; Peptic Ulcer; Secretin; Skin Diseases; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1982 |
Novel targets for the control of secretory diarrhoea.
Topics: Diarrhea; Enteric Nervous System; Enterocytes; Enterotoxins; Humans; Intestinal Absorption; Neprilysin; Octreotide; Serotonin Antagonists; Substance P | 2002 |
Pathogenesis and pharmacology of diarrhea.
Topics: Acetylcholine; Animals; Antidiarrheals; Bacterial Toxins; Biological Transport; Calcium; Catecholamines; Chlorides; Cyclic AMP; Cyclic GMP; Diarrhea; Fluid Therapy; Glucagon; Histamine; Intestinal Absorption; Intestinal Mucosa; Intestinal Secretions; Intestines; Lipid Metabolism; Loperamide; Regional Blood Flow; Serotonin; Sodium; Somatostatin; Substance P; Vasoactive Intestinal Peptide; Water-Electrolyte Balance | 1986 |
2 trial(s) available for substance p and Diarrhea
| Article | Year |
|---|---|
Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
Topics: Aged; Antineoplastic Agents, Hormonal; Calcitonin Gene-Related Peptide; Colon; Colonic Diseases; Diarrhea; Digestion; Double-Blind Method; Female; Flushing; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Histamine; Humans; Intestine, Small; Male; Malignant Carcinoid Syndrome; Middle Aged; Motilin; Neuropeptide Y; Neuropeptides; Neurotensin; Octreotide; Peptide YY; Placebos; Serotonin Antagonists; Substance P; Vasoactive Intestinal Peptide | 1997 |
Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome.
Topics: Calcium Channel Blockers; Colonic Diseases, Functional; Diarrhea; Female; Gastrointestinal Motility; Humans; Immunoenzyme Techniques; Male; Middle Aged; Morpholines; Neuropeptide Y; Parasympatholytics; Phenethylamines; Statistics, Nonparametric; Substance P; Surveys and Questionnaires; Treatment Outcome | 2000 |
14 other study(ies) available for substance p and Diarrhea
| Article | Year |
|---|---|
[Study on the mechanism of electroacupuncture repairing intestinal barrier via regulating mast cell in rats with diarrhea-predominant irritable bowel syndrome].
Topics: Acupuncture Points; Animals; Diarrhea; Electroacupuncture; Female; Irritable Bowel Syndrome; Mast Cells; Occludin; Rats; Rats, Sprague-Dawley; Substance P; Tryptases; Visceral Pain | 2023 |
Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Cell Count; Diarrhea; Female; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Mast Cells; Middle Aged; Rectum; Sex Factors; Substance P; Vasoactive Intestinal Peptide; Young Adult | 2014 |
Differential expression of enteric neuroimmune-network in invasive and acute watery diarrhoea.
Topics: Adolescent; Adult; Biopsy; Cholera; Diarrhea; Dysentery, Bacillary; Enteric Nervous System; Histamine; Humans; Male; Middle Aged; Nerve Growth Factor; Neurons; Rectum; Serotonin; Substance P; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide; Vibrio cholerae O1; Young Adult | 2010 |
Effects of Wei Chang An pill on enzyme activity and levels of vasoactive peptide and substance P in the small intestine of rats with compound diarrhea.
Topics: Animals; Colon; Diarrhea; Drugs, Chinese Herbal; Female; Humans; Intestine, Small; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 2012 |
Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome.
Topics: Adult; Aged; Biopsy; Case-Control Studies; Colon; Colonic Diseases, Functional; Constipation; Diarrhea; Female; Humans; Male; Middle Aged; Neuropeptide Y; Peptide YY; Substance P; Vasoactive Intestinal Peptide | 2003 |
Substance P expression correlates with severity of diarrhea in cryptosporidiosis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Animals; Chronic Disease; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Jejunum; Male; Middle Aged; RNA, Messenger; Substance P | 2003 |
Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation.
Topics: Animals; Bacterial Toxins; Clostridioides difficile; Corticotropin-Releasing Hormone; Diarrhea; Enterotoxins; Ileum; In Vitro Techniques; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Fibers; Peroxidase; Substance P | 2004 |
Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.
Topics: Adult; Calcitonin Gene-Related Peptide; Colonic Diseases, Functional; Diarrhea; Dysentery, Bacillary; Female; Follow-Up Studies; Humans; Interleukin-1; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Mast Cells; Nerve Fibers; Phosphopyruvate Hydratase; Risk Factors; Serotonin; Substance P | 2004 |
Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome?
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Budesonide; Cyclooxygenase 2; Cytokines; Diarrhea; Dinoprostone; Disease Models, Animal; Humans; Irritable Bowel Syndrome; Lymphocyte Activation; Membrane Proteins; Mice; Models, Biological; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Substance P; T-Lymphocytes; Trichinella spiralis; Trichinellosis | 2005 |
Beneficial effect of tachykinin NK1 receptor antagonism in the development of hapten-induced colitis in mice.
Topics: Animals; Capillary Permeability; Colitis; Colon; Diarrhea; Dinitrofluorobenzene; Disease Models, Animal; Haptens; Hypersensitivity; Indoles; Isoindoles; Male; Mast Cells; Mice; Mice, Inbred BALB C; Neurokinin-1 Receptor Antagonists; Substance P; Sulfonic Acids | 2006 |
CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.
Topics: Animals; Bacterial Toxins; Biphenyl Compounds; Cholera Toxin; Clostridioides difficile; Diarrhea; Enterocolitis; Enterotoxins; Ileum; Male; Mast Cells; Rats; Rats, Wistar; Substance P | 1994 |
Decreased substance P content in the rectal mucosa of diabetics with diarrhea and constipation.
Topics: Adult; Constipation; Diabetes Complications; Diabetes Mellitus; Diarrhea; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Rectum; Substance P | 1997 |
Treatment of gastric ulcers and diarrhea with the Amazonian herbal medicine sangre de grado.
Topics: Animals; Capsaicin; Cyclooxygenase 2; Diarrhea; Diffusion Chambers, Culture; DNA Primers; Dose-Response Relationship, Drug; Electric Stimulation; Gene Expression Regulation, Enzymologic; Guinea Pigs; Ileum; Interleukin-1; Interleukin-6; Intestinal Mucosa; Isoenzymes; Male; Neurons, Afferent; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peru; Phytotherapy; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; RNA, Messenger; Stomach Ulcer; Substance P; Tumor Necrosis Factor-alpha | 2000 |
[A preliminary study on substance P and vasoactive intestinal polypeptide contents in intestinal mucosa of chronic diarrhea with splenic weakness].
Topics: Adult; Chronic Disease; Diarrhea; Female; Humans; Intestinal Mucosa; Male; Splenic Diseases; Substance P; Vasoactive Intestinal Peptide | 1991 |